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An IQGAP-related protein controls actin-ring formation and
cytokinesis in yeast
J. Andrew Epp and John Chant
Background: Proteins of the IQGAP family have been identified as candidate
effectors for the Rho family of GTPases; however, little is known about their
cellular functions. The domain structures of IQGAP family members make them
excellent candidates as regulators of the cytoskeleton: their sequences include
an actin-binding domain homologous to that found in calponin, IQ motifs for
interaction with calmodulin, and a GTPase-binding domain. 
Results: The genomic sequence of Saccharomyces cerevisiae revealed a single
gene encoding an IQGAP family member (denoted IQGAP-related protein:
Iqg1). Iqg1 and IQGAPs share similarity along their entire length, with an amino-
terminal calponin-homology (CH) domain, IQ repeats, and a conserved carboxyl
terminus. In contrast to IQGAPs, Iqg1 lacks an identifiable GAP motif, a WW
domain, and IR repeats, although the functions of these domains in IQGAPs are
not well defined. Deletion of the IQG1 gene resulted in lethality. Cellular defects
included a deficiency in cytokinesis, altered actin organization, aberrant nuclear
segregation, and cell lysis. The primary defect appeared to be a cytokinesis
defect, and the other problems possibly arose as a consequence of this initial
defect. Consistent with a role in cytokinesis, Iqg1 co-localizes with an actin ring
encircling the mother–bud neck late in the cell cycle — a putative cytokinetic ring.
IQG1 overexpression resulted in premature actin-ring formation, suggesting that
Iqg1 activity temporally controls formation of this structure during the cell cycle. 
Conclusions: Yeast IQGAP-related protein, Iqg1, is an important regulator of
cellular morphogenesis, inducing actin-ring formation in association with
cytokinesis.
Background
Yeast provides an excellent system for analyzing cellular
morphogenesis [1,2]. Yeast cells are highly polarized during
vegetative cell division by budding, and the associated
cytoskeletal rearrangements have been well described
[3–6]. During G1, actin patches and actin cables polarize
towards the incipient bud site. As the bud emerges (S
phase), actin remains polarized to direct cell growth exclu-
sively to the bud. As bud growth completes (M phase), the
actin cytoskeleton transiently depolarizes and then reori-
ents towards the mother–bud junction to promote cytoki-
nesis and septum formation. Ultimately, cytoplasmic
microtubules from one spindle–pole body are directed
towards the bud cortex, and those from the opposite
spindle–pole body are directed towards the mother cortex.
The molecular mechanisms by which these cytoskeletal
rearrangements are achieved are not yet understood, and it
is likely that important regulators are yet to be described.
Cdc42 and other members of the Rho family of GTPases
are key regulators of cell polarization and cytoskeletal
rearrangements in eukaryotic cells [1,2,7,8]. Cdc42 is of
particular interest because it is conserved in sequence and
function from yeast to mammals [9–14]; however, it is not
yet known how Cdc42 exerts its effects on the cytoskele-
ton. In recent years, a number of Cdc42 effectors have
been described, including serine/threonine kinases of the
p21 Cdc42-/Rac-activated kinase (PAK) family [15–17],
ACK tyrosine kinase [18], molecules related to the
Wiskott–Aldrich syndrome protein (WASP) [19–21], a
yeast formin Bni1 [22–24], and the newly described
Gic1/Gic2 proteins [25–27]. Our understanding of the role
of each of these protein families in cytoskeletal polariza-
tion and rearrangement remains incomplete. In some
cases, the role ascribed to each effector is controversial
[28–30]. It remains quite likely that other unknown targets
are involved in eliciting the effects of Cdc42 on the
cytoskeleton, and also that the effects of Cdc42 are medi-
ated by several effectors acting in combination.
Recently, several lines of evidence have converged on a
novel class of molecules, the IQGAP family, as being pos-
sible cytoskeletal effectors of Cdc42 [31–37]. IQGAP1 and
IQGAP2 each possess a domain that is similar in structure
to the actin-binding domain of calponin, a protein that
interacts with actin filaments. Indeed, IQGAP1, which
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exists as a dimer, has been shown to bind and bundle actin
filaments [37]. IQGAP1 and IQGAP2 are able to bind
Cdc42 and, to a lesser extent, Rac [32,33,35]; and they
inhibit the GTP hydrolysis activity of Cdc42 [31,33,35], as
has been observed for other Cdc42 effectors [15]. Finally,
IQGAP family members bind calmodulin through their IQ
motifs [31,32,36,37], and calmodulin is able to modulate
the affinity of IQGAP1 for actin filaments and Cdc42 in
vitro [36,37]. Although this biochemical information is
intriguing, no definitive data in vivo have been reported to
prove or disprove a role for these molecules in controlling
cytoskeletal rearrangements. 
The discovery of a yeast IQGAP family member has pro-
vided a unique opportunity to analyze its cellular role in a
well-described, facile genetic system. Here, we report an
analysis of Iqg1 function and demonstrate a role for Iqg1
in actin-ring formation in association with cytokinesis.
Results
Comparison of the predicted domain structures of IQGAP
family members and Iqg1
The genomic sequence of Saccharomyces cerevisiae revealed
the presence an open-reading frame that encoded an
IQGAP-related protein, Iqg1 (ORF YPL242c). This 1495
amino-acid protein is essentially colinear with the
mammalian proteins, showing similarity along its entire
length and sharing several features with the mammalian
proteins (Figure 1a). In particular, Iqg1 possesses a
calponin-homology domain, IQ repeats, and a conserved
carboxy-terminal region (Figure 1b,c). Calponin is an
actin-filament-binding protein, and IQGAP1 has been
shown to bind and bundle actin [37]. IQ repeats are diag-
nostic of proteins that are able to bind calmodulin, such
as mammalian IQGAPs [31,36,37]. Although the carboxyl
termini of Iqg1 and mammalian IQGAPs are similar, Iqg1
lacks a Ras GTPase-activating protein (GAP) motif
present in the carboxy-terminal halves of mammalian
IQGAP1 and IQGAP2 [31–37]. This sequence initially
suggested that IQGAP molecules may bind Ras,
although no detectable affinity or activity towards Ras
has been observed for these proteins [31]. Rather,
IQGAP molecules have been shown to have affinity for
Cdc42, although GAP activity has never been detected
[31,35]. The exact role of the GAP consensus amino
acids in this interaction is not understood, and it may
well prove that Cdc42 or another GTPase interacts with
the carboxyl terminus of IQGAP via as yet undefined
regions. Therefore, despite the lack of a recognizable
GAP motif in the Iqg1 sequence, it remains possible that
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Figure 1
Alignment of Iqg1 to IQGAP1 and calponins.
(a) A schematic alignment between IQGAP1
and Iqg1 showing sequence domains and
percentage amino-acid sequence identity:
CH, calponin-homology domain; IR, IQGAP-
specific repeats; WW, WW domain; IQ, IQ
motifs; GRD, GAP-related domain. 
(b) Calponin-homology domain alignment of
IQGAP1 (GenBank accession number
L33075; amino acids 41–162), Iqg1 (amino
acids 105–220), chicken calponin (GenBank
accession number M63559; amino acids
25–134), and yeast calponin, Scp1 (amino
acids 23–139; open reading frame
YOR367W of the yeast genomic sequence).
Black boxes indicate consensus residues.
Grey boxes indicate IQGAP1–Iqg1 identities.
Dashes represent spaces to optimize the
alignment based on previously aligned
sequences [31]. (c) Alignment of IQ repeats.
The IQ sequence repeats shown begin at
amino acids 745, 775, 805 and 835 in
IQGAP1, and begin at amino acids 599, 626,
659, 687, and 717 in Iqg1. Black boxes
indicate consensus residues, based on
published alignments [31].
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Iqg1 binds Cdc42 or some other GTPase. However, we
have been unable to detect an interaction between Iqg1
and Cdc42 (data not shown).
Two additional sequence motifs of mammalian IQGAPs
are not shared by Iqg1. Specifically, mammalian IQGAP
proteins have a predicted WW domain, speculated to
mediate protein–protein interaction, and a repeated motif,
the IQGAP repeat (IR repeat) [31–37]. To date, the
precise functions of these domains are unknown. 
Finally, both mammalian IQGAP proteins and Iqg1 pos-
sess regions predicted to form a coiled coil. In Iqg1, a
coiled-coil structure is highly probable between residues
775 and 825; this region of mammalian IQGAPs is also
predicted to form a coiled coil based upon the coiled-coil
prediction algorithm [38,39]. IQGAP1 is known to dimer-
ize, potentially via this region [37].
Although the sequences of Iqg1 and IQGAP indicate
that they are members of a protein family, attempts to
replace Iqg1 function with IQGAP2 have been unsuc-
cessful (J.A.E., S. Brill, A. Bernards and J.C., unpublished
observations). Thus, to a certain extent, Iqg1 and IQGAPs
have diverged in function (see Discussion).
Iqg1 can associate with actin filaments
As IQGAP1 has been shown to associate with actin fila-
ments [37], we examined the ability of Iqg1 to bind actin.
Full-length Iqg1 protein, deletion derivatives and control
proteins (Bud2, Bud5 and luciferase) were tested for their
association with actin filaments in vitro by a sedimentation
assay. As illustrated in Figure 2, full-length Iqg1 and an
amino-terminal fragment of Iqg1 pelleted with actin sig-
nificantly, in contrast to control proteins. An Iqg1 frag-
ment lacking the calponin-homology domain showed no
significant association with actin over the background
shown by controls. Thus, we conclude that Iqg1, like
IQGAP1, can associate with actin filaments via its
calponin-homology domain. 
IQG1 is required for cell viability
Deletion of the IQG1 gene revealed that the encoded
product provides an essential cellular function (see Mat-
erials and methods for details). Figure 3 illustrates the null
phenotype of IQG1-deletion mutants as determined by
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Figure 2
Iqg1 protein associates with actin filaments.
Iqg1 protein fragments are shown
schematically. The black region represents the
calponin-homology domain. Bud2, Bud5 and
luciferase proteins serve as negative controls
for actin binding. Actin filaments are
exclusively found in the pellet (data not
shown).
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Figure 3
Requirement of IQG1 for cell viability.
Germination and outgrowth of two null (iqg1–)
and two wild-type (IQG1+) spores. Parent
strain: 1733.
meiotic tetrad analysis. As compared with wild-type segre-
gants germinated in parallel, iqg1 null cells became large
and misshapen and did not undergo cell separation. The
iqg1 nulls do not progress in growth beyond the stage illus-
trated and eventually lyse (data not shown). Lysis is 
suppressed by growth on an osmotic support (1 M sor-
bitol), although growth of the cells arrests at a similar ter-
minal phenotype (data not shown).
Iqg1-deficient cells exhibit a defect in cytokinesis
To analyze the loss-of-function phenotype of IQG1 in
detail, Iqg1 protein was depleted by repressing IQG1
expression using a regulatory promoter (MET3 [40]) in an
iqg1 deletion background. In a second experiment, the 
cellular defects of germinating spores of the iqg1 null
strain were analyzed. 
Depletion experiments showed that Iqg1 is required for
cytokinesis, actin organization and nuclear segregation.
Figure 4 illustrates the morphology, actin organization, and
nuclear segregation in cells as Iqg1 levels are reduced.
During time courses of Iqg1 depletion, cells first exhibited
a defect in cytokinesis (4 hours) with extensive defects in
actin organization and nuclear segregation occurring at later
times (6,9 hours). The timing of appearance of these
defects suggests that the latter defects probably result from
the primary cytokinesis defect, although we cannot exclude
the possibility that Iqg1 has several distinct functions. 
The morphology of cells in the depletion time course
demonstrates how a cytokinesis defect could lead to the
formation of multinucleate cells. Normally, once a
mother–bud pair divides, each progeny cell produces a
bud. However, the cells marked by arrowheads at the
4 hour time point, which did not undergo cytokinesis in
the previous cell cycle, are mother–bud pairs that com-
pleted nuclear division but initiated only one bud, rather
than two. This aberrant situation probably arose because
yeast cells are prevented from forming more than one bud
per cytoplasm [41]. Subsequent division of each nucleus
occurs in the common cytoplasm leading to four nuclei
with only three cell bodies, hence one cell body receives
two nuclei. This situation is probably exacerbated in sub-
sequent generations as reflected in the appearance of cells
with multiple nuclei at 6 and 9 hours.
Analysis of germinating IQG1–null spores revealed similar
defects. The heterozygous diploid strain (IQG1/iqg1) was
sporulated and then germinated in parallel with a wild-type
control strain in dilute conditions to prevent significant
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Figure 4
Analysis of the phenotype of cells depleted of
Iqg1. (a) Differential interference contrast
photographs of cells at the indicated time
points of a depletion time course. (b) Actin
and nuclear organization at the indicated time
points. All panels are composites of strain
1735, which has a doubling time of 2 h under
the media conditions used prior to methionine
addition.
(a)
0 h
(b)
0 h
Actin DNA
2 h 2 h
Actin DNA
4 h 4 h
Actin DNA
6 h
6 h
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mating. Morphologically aberrant cells accumulated only in
the cultures derived from the null heterozygote (Figure 5),
and these cells were similar in appearance to those
observed in the depletion time course above. Importantly,
it was clear that the germinating spores could polarize actin
through several nuclear cycles in which cytokinesis had
been defective, thereby underscoring the primary nature of
the cytokinesis defect (Figure 5a; polarized clusters of
actin dots are marked by arrowheads). 
Iqg1 localizes to a ring encircling the mother–bud neck
To further investigate the function of Iqg1, the subcellular
localization of Iqg1 was determined. An epitope-tagged
version of Iqg1 was constructed and shown to be entirely
functional by genetic complementation (data not shown).
As illustrated in Figure 6, Iqg1 protein localized to a single
ring encircling the mother–bud neck at around the time of
nuclear separation; this ring sometimes persisted on
unbudded cells after cytokinesis. As the ring of Iqg1
protein marks the cytokinesis site between mother and
bud, and as iqg1 mutants are deficient in cytokinesis, we
investigated whether actin was also present in these rings.
As illustrated in Figure 6b, Iqg1 and actin colocalized in
these ring structures. We speculate that this previously
described actin ring [42] may direct cytokinetic or secre-
tory activities to the imminent site of cell separation. Iqg1
did not localize to regions of polarized growth where
Cdc42 is most highly concentrated [43] — the bud site
and small buds during vegetative growth, and the tips of
mating projections (Figure 6 and data not shown). 
Iqg1 localization is not dependent upon actin
To determine whether Iqg1 localization was dependent
upon the actin ring, we examined the effects of the actin-
depolymerizing agent latrunculin A on the localization of
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Figure 5
Analysis of the phenotype of IQG1–null spores after germination. 
(a) Actin staining of IQG1–null spores during germination and growth.
Arrowheads indicate regions of polarized actin. (b) Nuclear distribution
of IQG1–null spores during germination and growth. Parent strain:
1733.
Figure 6
Subcellular localization of Iqg1. (a) The
localization of a functional epitope-tagged
version of Iqg1 protein throughout the cell
cycle. Iqg1 localizes as a ring at the neck
between mother and bud beginning at or
around the time of nuclear division (fourth
panel), and this ring persists until after cell
separation (fifth to eighth panels). Strain:
1737. (b) The colocalization of the Iqg1 ring
with an actin-ring structure encircling the
mother–bud neck. Three examples of large
budded cells are shown, and one example of
a post-cytokinesis cell is shown at the far
right. Strain 1737. (c) The effect of actin
depolymerization on Iqg1 localization: strain
1737 treated with latrunculin A for 15 min.
lqg1(a) (b)DNA
lqg1(c) DNAActin
lqg1
DNA
Actin
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Iqg1 [44]. As illustrated in Figure 6c, 200 µM latrunculin
A effectively eliminated polymerized actin within
15 minutes. In these cells, Iqg1 could still be seen as a ring
encircling the mother–bud neck. Thus, Iqg1 can remain
localized as a ring in the mother–bud neck in the absence
of an associated actin ring. 
Overexpression of IQG1 drives premature actin-ring
formation
IQG1 was overexpressed in an otherwise wild-type back-
ground to examine the relationship between Iqg1 activity
and actin-ring formation. As illustrated in Figure 7, expres-
sion of IQG1 from a high copy-number plasmid resulted in
the premature arrival of Iqg1 in the mother–bud neck and,
importantly, premature formation of an actin ring in that
location. Based on these data, we conclude that an
increased level of Iqg1 is sufficient to drive the formation
of an actin ring. 
Discussion
IQGAP molecules were originally identified in mammal-
ian cell systems as putative cytoskeletal regulators respon-
sive to GTPases. The genomic sequence of yeast has
revealed an IQGAP-related protein, Iqg1, which shares
the overall architecture of mammalian IQGAPs and has
considerable sequence similarity with these proteins.
Genetic and cell-biological approaches presented in this
paper have shown that Iqg1 is a regulator of actin-ring
formation and cytokinesis. 
Iqg1 controls actin-ring formation in association with
cytokinesis, but not polarized growth
Because IQGAPs of animals bind Cdc42, one possibility is
that these molecules would mediate Cdc42-directed actin
polarization in yeast [9,10] or filopodial formation in
mammalian cell systems [11,13]. Our data demonstrate
that this is not the case in yeast and, by extension, possi-
bly not the case in other eukaryotic cells. 
Several lines of evidence indicate that Iqg1 is most impor-
tant in cytokinesis. First, the most immediate defect ob-
served in Iqg1-depleted cells is a deficiency in cytokinesis.
Cells can be observed that have failed to perform cytokin-
esis for several rounds of nuclear division, yet retain polar-
ized cortical actin. Second, Iqg1 colocalizes in a ring struc-
ture at the site of cytokinesis in the mother–bud neck and
never shows localization to regions of polarized growth
where Cdc42 is concentrated. Third, overexpression of
IQG1 induces cytokinesis-associated actin-ring formation
prematurely in the cell cycle. Taken together, these argu-
ments support the conclusion that Iqg1 directs the building
of an actin-ring structure involved in cytokinesis. Whether
Iqg1 plays additional roles in the cell remains to be seen.
The relationship of Iqg1 function to Cdc42 function
Do Cdc42 and Iqg1 function together in yeast? Iqg1 lacks
the consensus residues that have been presumed to
mediate Cdc42 interaction, and we have not been able to
detect an interaction between Iqg1 and Cdc42 (unpub-
lished observations). This difference between the yeast
protein Iqg1 and the mammalian IQGAP family members
may reflect the fact that yeast and animal cells set up cyto-
kinetic rings by different hierarchies of regulation [45]. In
yeast, the location of the cytokinetic ring is constrained
early in G1 by the site of bud emergence, whereas in
animal cells the cytokinetic ring is set up to bisect the ves-
tiges of the spindle. In animal cells, Cdc42 has an active
role in cytokinesis [46]. Although yeast Cdc42 controls
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Figure 7
Overexpression of IQG1 results in premature
Iqg1 localization and actin-ring formation.
Quantitative analysis of the timing of Iqg1 and
actin-ring formation in (a) wild-type and (b)
IQG1-overexpressing strains in relation to
cell-cycle morphology. In (a), 302 cells of
strain 1737 were scored, and in (b), 357 cells
of strain 1738 were scored. Percentage of
cells within a category is shown.
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bud formation and thereby affects cytokinesis indirectly,
there is no indication that Cdc42 is directly involved in the
formation of an actin-ring structure, and Cdc42 is certainly
not localized at the mother–bud neck when Iqg1 becomes
localized at this region. These arguments make it a
reasonable possibility that Iqg1 and IQGAPs may both be
involved in cytokinetic actin-ring formation, but that Iqg1
may have lost the ability to bind Cdc42 because of the
different pathways to cytokinesis.
The mechanism of Iqg1 action and further issues
The data presented argue strongly that Iqg1 is an inducer
of actin-ring formation and that this ring participates in
cytokinesis. By what mechanism does Iqg1 induce actin-
ring formation? We propose a scheme for Iqg1 action
whereby Iqg1 is recruited to the mother–bud neck region
in a temporally specific manner. Once in the neck region,
Iqg1 bundles actin filaments into an ordered ring struc-
ture. This actin ring would then serve as a docking site for
secretory vesicles and possibly for myosin, thereby effect-
ing cytokinesis and cell separation. Consistent with this
view, myosin type II is known to localize to the
mother–bud neck region [47]. The temporally regulated
appearance of Iqg1 might be achieved by cell-cycle-spe-
cific production of the protein or by cell-cycle-specific
modification. The docking structure responsible for Iqg1
localization is not known, but septins or septin-associated
factors are appealing candidates, as septins regulate much
of the trafficking of proteins to the neck region. The role
of calmodulin in this scheme remains speculative. Cal-
modulin has been shown to localize to the mother–bud
neck region late in the cell cycle [48], at a time following
the initiation of Iqg1 localization. No cytokinetic role for
calmodulin has yet been reported; however, the effects of
mutations in the calmodulin gene are complex and might
mask such a role [49,50]. The observation that calmodulin
reduces the affinity of IQGAP1 for actin filaments [37]
suggests that calmodulin might induce Iqg1 to be released
from the actin-ring structure thus allowing other factors to
bind or possibly causing disassembly of the ring. 
Conclusions
IQGAP-type proteins are broadly conserved from mammals
to yeast and, on the basis of sequence similarities, have
been postulated to modulate actin dynamics. The findings
presented here indicate that Iqg1 is absolutely required for
cytokinesis and that Iqg1 is an inducer of an actin-ring
structure that defines the cytokinetic plane in yeast.
Materials and methods
Strains, growth conditions, genetic methods, and manipulation
of DNA
Yeast strains and plasmids are listed in Table 1. Standard yeast genetic
methods and media were used unless specified [51]. DNA was manipu-
lated by standard methods [52]. Yeast transformations were performed
by the lithium acetate method [53] for integrative transformations and
the one-step protocol [54] for non-integrative transformations. 
Isolation and deletion of IQG1
IQG1 corresponds to open-reading frame YPL242c of the S. cere-
visiae genomic sequence. A DNA fragment carrying IQG1 was isolated
from the Rose library [55] by colony hybridization using end-labeled
oligonucleotide probes [52] (IQG1-A 5′-CGGAGCTTGCGAATGCG
CCGTGCG3′; IQG1-B 5′-CTGAATACGGCGTGCCTGAGTG-3′). A
minimal IQG1 clone was reconstructed by ligating three DNA frag-
ments together into pSP72 (Promega) to produce p1828. An internal
PstI–BamHI IQG1 fragment was inserted into pSP72. The region 5′ of
the PstI site to 800 nucleotides upstream of the IQG1 initiation codon
was amplified by PCR and ligated to the PstI–BamHI fragment via
PvuII and PstI sites (primers: IQG1-A; IQG1-C 5′-CTTGTTATAGA-
GATCTTGCAATTC-3′. The region 3′ from the BamHI site to
950 nucleotides downstream of the stop codon was PCR-amplified
and ligated via BamHI and EcoRV sites to complete the minimal con-
struct p3.2. (Primers: IQG1-D 5′-GGCTTTTTGGATCCATTGAACC
AG-3′; IQG1-F 5′-GGCTCGAGCAAGAGCCCTCAGCTTCTCAAG
TG 3′). A XhoI fragment containing the minimal clone from p1828 (one
XhoI site from pSP72 and one from IQG1-F primer) was transferred
into the XhoI site of p1829 (previously modified from YCPlac22 by lig-
ating a XhoI linker into the SmaI site) to generate p1831. An IQG1
clone beginning 3 nucleotides upstream of the ATG start was pro-
duced in pSP72 by similar means except that primer IQG-E was sub-
stituted for IQG-A, producing p1835 (primers: IQG1-E 5′-ACAATGA
CAGCATATTCAGGCTCTCC-3′; IQG1-C; IQG1-D; IQG1-F). The
IQG1 open-reading frame was entirely replaced by a kanamycin/G418
resistance cassette generated by amplifying the kanR marker from the
plasmid pUG6 [56] using oligonucleotide primers. (IQG1-KO1 5′-
GCACCAGTTCAATTATATGTAACAAGGTGGTGCAAAAACAGCAT-
AGGCCACTAGTGGATCTG-3′; IQG1-KO2 5′-GTAACAGCTTTTG
CCCAATATGCTCAAAACCGAGTTATCTCAGCTGAAGCTTCGTAC-
GC-3′). The replacement cassette was transformed into the diploid
strain 52 and transformants were selected on 200 mg/L G418
Research Paper  Yeast IQGAP controls cytokinesis Epp and Chant    927
Table 1
Yeast strains and plasmids used in this study.
Yeast strains:
Name Relevant genotype Source
52 MATa/MATα his4/his4 trp1/trp1 ura3/ura3 [58]
1237-13C MATα his4 trp1 ura3 [58]
1733 MATa/MATα his4/his4 trp1/trp1 ura3/ura3 This study
IQG1/iqg1::kanR
1734 MATa his4 trp1 ura3 iqg1::kanR carrying p1831 This study
1735 MATa his4 trp1 ura3 iqg1::kanR carrying p1832 This study
1736 MATa his4 trp1 ura3 iqg1::kanR carrying p1833 This study
1737 MATa/MATα his4/his4 trp1/trp1 ura3/ura3 This study
IQG1/iqg1::kanR carrying p1833
1738 MATa/MATα his4/his4 trp1/trp1 ura3/ura3 This study
IQG1/iqg1::kanR carrying p1834
1739 MATα his4 trp1 ura3 carrying p1833 This study
Plasmids:
Name Description Source
YCplac22 ARS-CEN-containing, TRP1-containing vector [59]
YEplac112 2µ-containing, TRP1-containing vector [59]
p1831 IQG1 in YCplac22 This study
p1832 MET3-promoter-controlled IQG1 carried in YCplac22 This study
p1833 IQG1–HA fusion carried in YCplac22 This study
p1834 IQG1–HA fusion carried in YEplac112 This study
p1835 IQG1 under the control of the SP6 promoter in pSP72 This study
p1836 3′ deletion of IQG1, under the control of the SP6 This study
promoter in pSP72
p1837 5′ deletion of IQG1, under the control of the SP6 This study
promoter in pSP72
(Gibco/BRL). Transformants heterozygous for the IQG1 deletion were
identified by diagnostic PCR (Primers: IQG1-B; KAN 5′-TCGCACCT-
GATTGCCCG-3′). IQG1/iqg1::kanR diploids yielded two viable and
two inviable meiotic progeny. All viable progeny were kanS indicating
that only wild-type spores produced viable progeny. Transformation of
the minimal IQG1 plasmid into the heterozygous diploid allowed kanR
spores to produce colonies indicating that the lethality observed was
due to a deficiency in IQG1. 
Cytological analysis of iqg1 mutants
The iqg1 mutants were analyzed by two methods: repression of expres-
sion of the sole IQG1 from the MET3 promoter [40] and analysis of
spores during germination and outgrowth. The methionine-repressible
IQG1 construct was produced by ligating a HindIII–PstI promoter frag-
ment derived from plasmid p3.90 into the corresponding sites of
YCplac22 creating p1830. A XhoI–BglII fragment carrying IQG1 and
derived from p3.1 was ligated into the SalI–BamHI site of YCplac22-
MET3 to create a plasmid with IQG1 under control of the MET3 pro-
moter. MET repression time course: the strain 1735, grown overnight
in SC minus MET medium [51] was diluted 50-fold into SC minimal
media at 30°C. Growth was permitted for 2.5 h and methionine was
added to 4 mM to repress IQG1 expression. Samples of cultures were
removed at regular time points and immediately fixed in 3.7% formalde-
hyde. Spore germination time course: sporulated strains 1733
(IQG1/iqg1::KANR) and 52 (IQG1/IQG1) were digested and soni-
cated to disperse tetrads to single spores. Samples were germinated
in 10 ml of liquid medium (YPD plus 1 M sorbitol) in petri dishes and
fixed at regular time points. All samples were examined thoroughly to
verify that the aberrant cells illustrated in Figure 5 were specifically
observed in the cultures derived from 1733. Samples from both time
course experiments were stained for actin (rhodamine phalloidin) and
DNA (Hoechst) [57]. Samples were observed and photographed with
a Nikon Microphot SA epifluorescence microscope. 
Subcellular localization of an epitope-tagged Iqg1 protein 
IQG1 fused in-frame to a triple epitope tag was produced as follows. A
NotI site was generated at the extreme 3′ end of the IQG1 open
reading frame by site-directed PCR (IQG1-D; IQG1-HA3-NOT-1 5′-
GCTCTCCTAGATCTTTAGCGGCCGCGCAAAGCGTTCCTTTTATA-
GAAAAAACTG-3′; IQG1-HA3-NOT-2 5′-GCTCTCCTGCGGCC
GCTAATAGATAACTCGGTTTTGAG-3′; T7 5′-TAATACGACTCAC-
TATA-3′). The resulting BamHI–BglII fragment was ligated into plasmid
SP72, then liberated and used to replace the BamHI–BamHI fragment
of plasmid p3.2, thereby producing IQG1 with a NotI site at its carboxyl
terminus. A triple HA epitope flanked by NotI sites was PCR-amplified
from plasmid pB55 (originally from Tyers, Tokiwa and Futcher) and
ligated into the NotI site to generate p1833 (T7 and T3 primers; Strata-
gene). IQG1-HA was shown to be functional by complementation of a
iqg1 null mutation. To produce a high copy-number plasmid the
XhoI–BamHI fragment of IQG1 from p3.2 was ligated to the SalI-
–BamHI sites of YEplac112. The IQG1 3′ end with a NotI site carried
on a BamHI–BglII fragment was ligated into the BamHI site of the
YEplac112 derivative and the NotI HA epitope fragment was subse-
quently ligated into the NotI site, generating p1834. Indirect immunoflu-
orescence of the Iqg1–HA protein was performed by standard
methods [54] using the anti-HA antibody 11HA (Babco) at 1:200 dilu-
tion and FITC-conjugated goat anti-mouse antibody (Jackson Immuno-
logicals). Samples were observed and photographed with a Nikon
Microphot SA epifluorescence microscope. 
Pheromone and latrunculin A treatments
Mating projections were induced by exposing cells of strain 1736 to
8 mg/ml synthetic α-factor (Sigma) for 2 h at 30°C. For latrunculin
treatments, strain 1737 was grown to exponential phase and latrun-
culin A (Molecular Probes) from a 10 mM DMSO stock was added to a
final concentration of 200 µM. For control cells an equal amount of
DMSO alone was added. The cells were incubated at 30°C for 15 min
and immediately fixed in 3.7% formaldehyde.
In vitro expression of Iqg1 proteins
Full-length Iqg1 was expressed in vitro from plasmid p1835 using TNT
SP6 coupled Reticulocyte Lysate (Promega), with 35S-labelled methio-
nine (Amersham). To make a CH-domain-containing amino-terminal
fragment from amino acids 1–538, a linker containing stop codons in
all three reading frames was inserted in the EcoRV site of IQG1 in
pl835 to generate p1836 (Linker: CTAGTCTAGACTAG). To express a
carboxy-terminal fragment lacking the CH domain, an EcoRV fragment
beginning at amino acid 548 was ligated behind the SP6 promoter in
SP72 to generate p1837.
Actin binding assays
Monomeric rabbit skeletal muscle actin (Cytoskeleton, Denver) was
polymerized at 0.3 mg/ml in A-buffer (2 mM Tris pH 8.0, 0.2 mM CaCl2,
0.2 mM ATP, 0.5 mM DTT, 5% sucrose), by the addition of 50 mM KCl,
100 mM MgCl2, and 50 mM ATP for 1 h at 24°C. To study the actin-
binding potential of proteins expressed in vitro, 25 µl of TNT reaction
was diluted in 2 × A buffer and added to 50 µl of polymerized actin in
0.1mg/ml bovine serum albumin. The samples were incubated for
30 min at room temperature, and centrifuged at 100,000 rpm at 20°C
for 20 min in TL-100 Ultracentrifuge (Beckman Instruments), using a
TL-100.1 rotor. The supernatant was pipetted off, and the pellet was
resuspended in an equal volume of A buffer. Equal aliquots of super-
natant and pellet were resolved by SDS–PAGE on 10% polyacry-
lamide gels. The ratio of protein in the pellet compared with that in the
supernatant was quantitated using a Fuji BAS 2000 phosphorimager.
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